Tower Research Capital (TRC)’s Janux Therapeutics JANX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $90.7K | Buy |
3,928
+2,502
| +175% | +$57.8K | ﹤0.01% | 2461 |
|
|
2025
Q1 | $38.5K | Sell |
1,426
-2,401
| -63% | -$64.8K | ﹤0.01% | 2415 |
|
|
2024
Q4 | $205K | Buy |
3,827
+3,436
| +879% | +$184K | ﹤0.01% | 1702 |
|
|
2024
Q3 | $17.8K | Sell |
391
-2,189
| -85% | -$99.4K | ﹤0.01% | 3298 |
|
|
2024
Q2 | $108K | Buy |
2,580
+1,321
| +105% | +$55.3K | ﹤0.01% | 2531 |
|
|
2024
Q1 | $47.4K | Sell |
1,259
-509
| -29% | -$19.2K | ﹤0.01% | 2312 |
|
|
2023
Q4 | $19K | Buy |
1,768
+460
| +35% | +$4.94K | ﹤0.01% | 3680 |
|
|
2023
Q3 | $13.2K | Sell |
1,308
-289
| -18% | -$2.91K | ﹤0.01% | 3822 |
|
|
2023
Q2 | $19K | Sell |
1,597
-1,747
| -52% | -$20.7K | ﹤0.01% | 3417 |
|
|
2023
Q1 | $40K | Buy |
3,344
+2,003
| +149% | +$24K | ﹤0.01% | 2707 |
|
|
2022
Q4 | $18K | Buy |
1,341
+186
| +16% | +$2.5K | ﹤0.01% | 3218 |
|
|
2022
Q3 | $16K | Sell |
1,155
-809
| -41% | -$11.2K | ﹤0.01% | 4128 |
|
|
2022
Q2 | $24K | Buy |
1,964
+722
| +58% | +$8.82K | ﹤0.01% | 3604 |
|
|
2022
Q1 | $18K | Sell |
1,242
-142
| -10% | -$2.06K | ﹤0.01% | 3631 |
|
|
2021
Q4 | $27K | Buy |
1,384
+862
| +165% | +$16.8K | ﹤0.01% | 3345 |
|
|
2021
Q3 | $11K | Buy |
+522
| New | +$11K | ﹤0.01% | 4228 |
|